menu search

Dbv technologies shares jump on positive data from peanut allergy trial in toddlers

DBV Technologies SA's (NASDAQ: DBVT) pivotal Phase 3 EPITOPE trial of Viaskin peanut 250 µg for peanu...

June 8, 2022, 7:24 am

J.m. smucker says peanut butter recall to weigh on fiscal 2023 results

JM Smucker Co. shares SJM, +0.40% slid 3.5% in premarket trade Tuesday, after the parent to brands inlcuidng Folgers, Jif and Milk-Bone posted better-...

June 7, 2022, 7:08 am

More products with jif peanut butter recalled over salmonella concerns

Several companies have recalled products that contain Jif peanut butter amid an outbreak of salmonel...

May 26, 2022, 2:25 pm

Smucker (sjm) stock dips on jif peanut butter recall

J M Smucker (SJM) stock is falling on Monday after the food company announced a recall of Jif peanut bu...

May 23, 2022, 12:05 pm

J.m. smucker is recalling some jif peanut butter products due to salmonella

J.M. Smucker is recalling certain types of Jif peanut butter in the US because of a potential salmonell...

May 22, 2022, 9:10 am

Hormel is recalling 161,692 pounds of skippy peanut butter

Hormel Foods is recalling thousands of pounds of Skippy peanut butter because of stainless steel fragme...

March 31, 2022, 11:27 pm

2 dirt cheap biotechs to buy if you're a contrarian

Today's losers are selling for peanuts, and they just might become tomorrow's winners....

March 5, 2022, 11:07 am

2 dirt cheap biotechs to buy if you're a contrarian

Today's losers are selling for peanuts, and they just might become tomorrow's winners....

March 5, 2022, 11:07 am

Allergy therapeutics primed for a pivotal year

Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...

March 3, 2022, 3:58 am

Allergy therapeutics primed for a pivotal year

Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...

March 3, 2022, 3:58 am

Allergy therapeutics primed for a pivotal year

Allergy Therapeutics PLC (AIM:AGY) said it was primed for a pivotal year as it prepared to get two key clinical trials underway. A ground-breaking pha...

March 3, 2022, 3:58 am

Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial

Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...

January 26, 2022, 3:21 am

Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial

Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...

January 26, 2022, 3:21 am

Allergy therapeutics shares up 9% after it gets the fda green light to begin phase i peanut allergy trial

Shares in Allergy Therapeutics PLC (AIM:AGY) rose 9% in early trade after the group said the US regulator had given the green light for trials to begi...

January 26, 2022, 3:21 am


Search within

Pages Search Results: